Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript March 5, 2026
Evogene Ltd. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.26.
Operator: Welcome to Evogene’s Fourth Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded, March 5, 2026. Before we begin, I would like to caution that certain statements made during this earnings conference call by Evogene’s management will constitute...
